BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15719375)

  • 1. Parathyroid carcinoma.
    Mittendorf EA; McHenry CR
    J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
    Raue F; Haag Ch; Frank-Raue K
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
    Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
    Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
    Guarnieri V; Bisceglia M; Bonfitto N; Cetani F; Marcocci C; Minisola S; Battista C; Chiodini I; Cole DE; Scillitani A
    Surgery; 2008 Nov; 144(5):839-40. PubMed ID: 19081034
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
    Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
    Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
    Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT
    Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
    Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
    Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
    Hahn MA; Marsh DJ
    Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
    Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
    N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
    Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
    Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
    Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
    Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid carcinoma.
    Rawat N; Khetan N; Williams DW; Baxter JN
    Br J Surg; 2005 Nov; 92(11):1345-53. PubMed ID: 16237743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.